Philippe Karoyan
Inventor
Stats
- 1 US patents issued
- 9 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 1 US Patents Issued
- 9 US Applications Filed
- 5 Total Citation Count
- Jun 27, 2023 Most Recent Filing
- Jun 6, 2013 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| UNIVERSITE PARIS DESCARTES | 2
1 | 2013
2017 |
| UNIVERSITE PARIS DIDEROT - PARIS 7 | 2
1 | 2013
2017 |
| ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS | 2
1 | 2013
2017 |
| INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) | 2
1 | 2013
2017 |
| UNIVERSITE PIERRE ET MARIE CURIE UPMC | 2
1 | 2013
2017 |
Inventor Addresses
| Address | Duration |
|---|---|
| Courson-Monteloup, FR | Jul 25, 19 - Sep 19, 23 |
| Paris, FR | May 07, 15 - Dec 28, 23 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 8 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 5 |
| C07K: | PEPTIDES | 8 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2023/0414,702 | 2023 | COMPOUNDS AND PHARMACEUTICAL USE THEREOF IN THE TREATMENT OF CANCER | 0 |
| 11759496 | 2023 | Compounds and pharmaceutical use thereof in the treatment of cancer | 0 |
| 11306124 | 2022 | Agonist agents of CD47 inducing programmed cell death and their use in the treatments of diseases associated with defects in programmed cell death | 0 |
| 2022/0000,967 | 2022 | SYNTHETIC PEPTIDES INDUCING IMMUNOGENIC CELL DEATH | 0 |
| 11142548 | 2021 | Agents that activate CD47 and their use in the treatment of inflammation | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.